253 related articles for article (PubMed ID: 2547935)
81. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
[TBL] [Abstract][Full Text] [Related]
82. Estimation of affinities and efficacies for kappa-receptor agonists in guinea-pig ileum.
Leff P; Dougall IG
Br J Pharmacol; 1989 Mar; 96(3):702-6. PubMed ID: 2541848
[TBL] [Abstract][Full Text] [Related]
83. Effects of 5-HT and alpha 1 adrenoceptor antagonists on kappa opioid-induced sedation.
Leighton GE; Hill RG; Hughes J
Pharmacol Biochem Behav; 1988 Dec; 31(4):899-904. PubMed ID: 2855271
[TBL] [Abstract][Full Text] [Related]
84. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
Bhargava HN; Gulati A; Ramarao P
Biochem Pharmacol; 1991 Jun; 42(1):25-9. PubMed ID: 1648922
[TBL] [Abstract][Full Text] [Related]
85. Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly).
Bhargava HN; Ramarao P
Prog Clin Biol Res; 1990; 328():493-6. PubMed ID: 2154810
[No Abstract] [Full Text] [Related]
86. Involvement of biogenic amines with the mechanisms of novel analgesics.
Vonvoigtlander PF; Lewis RA; Neff GL; Triezenberg HJ
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):651-6. PubMed ID: 6141608
[TBL] [Abstract][Full Text] [Related]
87. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
Stein C; Millan MJ; Yassouridis A; Herz A
Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
[TBL] [Abstract][Full Text] [Related]
88. Alpha 7-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (-)-nicotine and U-50,488H in beta-amyloid peptide (25-35)-treated mice.
Hiramatsu M; Watanabe M; Baba S; Kojima R; Nabeshima T
Ann N Y Acad Sci; 2004 Oct; 1025():508-14. PubMed ID: 15542756
[TBL] [Abstract][Full Text] [Related]
89. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats.
Tejwani GA; Rattan AK; Koo KL; Matwyshyn GA; Bhargava HN
Pharmacology; 1994 Apr; 48(4):216-25. PubMed ID: 8177908
[TBL] [Abstract][Full Text] [Related]
90. Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice.
Leander JD
Eur J Pharmacol; 1988 Jul; 151(3):457-61. PubMed ID: 2850923
[TBL] [Abstract][Full Text] [Related]
91. 5-HT3 receptor antagonists inhibit the response of kappa opioid receptors in the morphine-induced Straub tail [corrected].
Hasegawa Y; Kurachi M; Okuyama S; Araki H; Otomo S
Eur J Pharmacol; 1990 Nov; 190(3):399-401. PubMed ID: 2176986
[TBL] [Abstract][Full Text] [Related]
92. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
Pharmacol Biochem Behav; 1994 May; 48(1):87-91. PubMed ID: 8029307
[TBL] [Abstract][Full Text] [Related]
93. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
Ukai M; Suzuki M; Mamiya T
J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
[TBL] [Abstract][Full Text] [Related]
94. Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat.
Hayes AG; Skingle M; Tyers MB
Br J Pharmacol; 1986 Aug; 88(4):867-72. PubMed ID: 3017495
[TBL] [Abstract][Full Text] [Related]
95. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
Fukagawa Y; Katz JL; Suzuki T
Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
[TBL] [Abstract][Full Text] [Related]
96. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice.
Itoh J; Ukai M; Kameyama T
Brain Res; 1993 Aug; 619(1-2):223-8. PubMed ID: 8397052
[TBL] [Abstract][Full Text] [Related]
97. Effect of the kappa-receptor agonist, U-50,488H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task.
Ohno M; Yamamoto T; Ueki S
Eur J Pharmacol; 1991 Feb; 193(3):357-61. PubMed ID: 1647321
[TBL] [Abstract][Full Text] [Related]
98. Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H.
Milanés MV; Rabadan JV; Marin MT; Laorden ML
J Auton Pharmacol; 1998 Dec; 18(6):371-5. PubMed ID: 9915602
[TBL] [Abstract][Full Text] [Related]
99. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
Schmauss C
Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
[TBL] [Abstract][Full Text] [Related]
100. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Cooper SJ; Jackson A; Kirkham TC
Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
